SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-004342
Filing Date
2018-06-08
Accepted
2018-06-08 11:13:04
Documents
4
Period of Report
2018-06-27
Effectiveness Date
2018-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2235968zdef14a.htm DEF 14A 581934
2 G143662CAI001.GIF g143662cai001.gif GRAPHIC 131115
3 G143662CAI002.GIF g143662cai002.gif GRAPHIC 146082
4 G507891.JPG g507891.jpg GRAPHIC 16711
  Complete submission text file 0001047469-18-004342.txt   988257
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36020 | Film No.: 18888431
SIC: 2834 Pharmaceutical Preparations